Papers

6

Total Citations

35

H-Index

4

About

Hiroki Ito is a leading urologic surgeon and researcher whose work centers on advancing robot-assisted partial nephrectomy (RAPN) for complex renal tumors. His major contributions include systematically defining how complete endophytic renal tumors (CERTs) impact surgical, functional, and oncological outcomes—a study that has already garnered 13 citations since 2024. Ito has also pioneered comparisons of clamping techniques, showing that artery-and-vein clamping may not cause more renal damage than artery-only clamping in moderate- to high-complexity masses, a finding with 7 citations. His innovative use of tumor surface roughness as a preoperative predictor of surgical difficulty (5 citations) offers a novel tool for surgical planning. Additionally, his propensity-matched analyses of hilar versus non-hilar tumors and the influence of chronic kidney disease stages on RAPN outcomes have shaped perioperative risk stratification. Ito’s work extends to prostate cancer, where he explored robot-assisted radical prostatectomy for oligometastatic castration-resistant disease. With over 35 total citations across his most-cited papers, Ito’s research directly improves surgical decision-making and patient outcomes in minimally invasive urologic oncology.

Research Focus

Key Achievements

4
H-Index
6
Papers
35
Total Citations
6
Avg Citations/Paper
🏆 Most Cited Paper
Impacts of Complete Endophytic Renal Tumors on Surgical, Functional, and Oncological Outcomes of Robot-Assisted Partial Nephrectomy
13 citations · 2024
📈 Most Prolific Year: 2024 (3 Papers)
🤝 Key Collaborators: 31
🏛 Institutions: Yokohama City University Hospital, Yokohama City University, National Hospital Organization

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago